- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
249 results
2045 Exhibit: Shayegan et al, Atypical Antipsychotics Matching Receptor Profile to...
Document
IPR2020-01053, No. 2045-94 Exhibit - Shayegan et al, Atypical Antipsychotics Matching Receptor Profile to Individual Patients Clinical Profile (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2098 Exhibit: Zhuo et al, Topiramate and Metformin Are Effective Add OnTreatmen...
Document
IPR2020-01053, No. 2098-147 Exhibit - Zhuo et al, Topiramate and Metformin Are Effective Add OnTreatments in Controlling Anti Psychotic Weight Gain (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2088 Exhibit: Mak et al, Cost Savings Associated with Improved Adherence Among...
Document
IPR2020-01053, No. 2088-137 Exhibit - Mak et al, Cost Savings Associated with Improved Adherence AmongPatients with Schizophrenia Using Lurasidone (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2052 Exhibit: Hoyberg et al, Risperidone versus perphenazine in the treatment ofch...
Document
IPR2020-01053, No. 2052-101 Exhibit - Hoyberg et al, Risperidone versus perphenazine in the treatment ofchronic schizophrenic patients with acute exacerbations (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2131 Exhibit: Declaration of Dr Stephen Stahl
Document
IPR2020-01053, No. 2131-148 Exhibit - Declaration of Dr Stephen Stahl (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2142 Exhibit: News Release Sunovion Pharmaceuticals Inc Announces FDAApprov...
Document
IPR2020-01053, No. 2142-160 Exhibit - News Release Sunovion Pharmaceuticals Inc Announces FDAApproval of Latuda lurasidone HCl as Monotherapy andAdjunctive Therapy in Adult Patient...
|
|
Cite Document
2140 Exhibit: M��ller, J Clin Psych
Document
IPR2020-01053, No. 2140-158 Exhibit - M��ller, J Clin Psych (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2097 Exhibit: Poyurovsky et al, Attentuating Effect of Reboxetine on Appetite andW...
Document
IPR2020-01053, No. 2097-146 Exhibit - Poyurovsky et al, Attentuating Effect of Reboxetine on Appetite andWeight Gain in Olanzapine Treated Schizophrenia Patients (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2133 Exhibit: Declaration of Scott Stancell Condron
Document
IPR2020-01053, No. 2133-151 Exhibit - Declaration of Scott Stancell Condron (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2134 Exhibit: Deposition Transcript of Dr Thomas Kosten
Document
IPR2020-01053, No. 2134-152 Exhibit - Deposition Transcript of Dr Thomas Kosten (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2135 Exhibit: Hummel et al, Clozapine as Add On Medication in the MaintenanceTr...
Document
IPR2020-01053, No. 2135-153 Exhibit - Hummel et al, Clozapine as Add On Medication in the MaintenanceTreatment of Bipolar and Schizoaffective Disorder (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2085 Exhibit: Ng Mak et al, Efficacy and Metabolic Effects of Lurasidone VersusBre...
Document
IPR2020-01053, No. 2085-134 Exhibit - Ng Mak et al, Efficacy and Metabolic Effects of Lurasidone VersusBrexpiprazole in Schizophrenia (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2084 Exhibit: Ng Mak et al, Patient Preferences for Important Attributes of BipolarD...
Document
IPR2020-01053, No. 2084-133 Exhibit - Ng Mak et al, Patient Preferences for Important Attributes of BipolarDepression Treatments (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2050 Exhibit: Lieberman et al, Effectiveness of Antipsychotic Drugs in Patientswith...
Document
IPR2020-01053, No. 2050-99 Exhibit - Lieberman et al, Effectiveness of Antipsychotic Drugs in Patientswith Chronic Schizophrenia (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
2077 Exhibit: Albright, Three key antipsychotics lose patent protection
Document
IPR2020-01053, No. 2077-127 Exhibit - Albright, Three key antipsychotics lose patent protection (P.T.A.B. Mar. 11, 2021)
|
|
Cite Document
